Perceptive Xontogeny Venture Fund, LP
CIK 1757940 · last filed 2024-02-05
Perceptive Xontogeny Venture Fund, LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider bought $120.0M of ATXS on Feb 5, 2024. Across all open-market trades the lifetime net is +$178.4M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$178.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | 4,873,721 | $12.58 | $61.31M | $178.35M | 3 | 2024-02-05 |
| Landos Biopharma, Inc. (LABP) Delisted | 10%+ Owner | — | $22.93 | — | $0 | 1 | 2023-01-11 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-05 | Astria Therapeutics, Inc. (ATXS) Delisted | Buy (P) | +9,925,400 | $120.00M | EDGAR |
| 2023-12-22 | Astria Therapeutics, Inc. (ATXS) Delisted | Buy (P) | +2,960,000 | $18.35M | EDGAR |
| 2023-01-11 | Landos Biopharma, Inc. (LABP) Delisted | Buy (P) | — | $0 | EDGAR |
| 2022-12-21 | Astria Therapeutics, Inc. (ATXS) Delisted | Buy (P) | +3,633,060 | $40.00M | EDGAR |